In the general population, APOE4 carrier status is associated with an increased risk for the presence of AD-pathology (Schipper, 2011; Verghese et al., 2011; Liu et al., 2013; Jack et al., 2019; Yamazaki et al., 2019). The gene discussed is APOE; the disease is Alzheimer disease.